162 related articles for article (PubMed ID: 23468873)
1. The CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer.
Szász AM; Li Q; Eklund AC; Sztupinszki Z; Rowan A; Tőkés AM; Székely B; Kiss A; Szendrői M; Győrffy B; Szállási Z; Swanton C; Kulka J
PLoS One; 2013; 8(2):e56707. PubMed ID: 23468873
[TBL] [Abstract][Full Text] [Related]
2. A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials.
Spears M; Yousif F; Lyttle N; Boutros PC; Munro AF; Twelves C; Pritchard KI; Levine MN; Shepherd L; Bartlett JM
Oncotarget; 2015 Oct; 6(31):31693-701. PubMed ID: 26372731
[TBL] [Abstract][Full Text] [Related]
3. A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial.
Spears M; Lyttle N; D'Costa A; Chen BE; Yao CQ; Boutros PC; Burnell M; Levine MN; O'Brien P; Shepherd L; Bartlett JM
Oncotarget; 2016 Aug; 7(31):49099-49106. PubMed ID: 27056899
[TBL] [Abstract][Full Text] [Related]
4. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer.
Roylance R; Endesfelder D; Gorman P; Burrell RA; Sander J; Tomlinson I; Hanby AM; Speirs V; Richardson AL; Birkbak NJ; Eklund AC; Downward J; Kschischo M; Szallasi Z; Swanton C
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2183-94. PubMed ID: 21784954
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Miller ET; You S; Cadaneanu RM; Kim M; Yoon J; Liu ST; Li X; Kwan L; Hodge J; Quist MJ; Grasso CS; Lewis MS; Knudsen BS; Freeman MR; Garraway IP
BMC Cancer; 2020 May; 20(1):398. PubMed ID: 32380981
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical relationship between chromosomal instability and survival outcome in cancer.
Birkbak NJ; Eklund AC; Li Q; McClelland SE; Endesfelder D; Tan P; Tan IB; Richardson AL; Szallasi Z; Swanton C
Cancer Res; 2011 May; 71(10):3447-52. PubMed ID: 21270108
[TBL] [Abstract][Full Text] [Related]
7. High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability.
Matson DR; Denu RA; Zasadil LM; Burkard ME; Weaver BA; Flynn C; Stukenberg PT
BMC Cancer; 2021 Feb; 21(1):186. PubMed ID: 33622270
[TBL] [Abstract][Full Text] [Related]
8. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.
Carter SL; Eklund AC; Kohane IS; Harris LN; Szallasi Z
Nat Genet; 2006 Sep; 38(9):1043-8. PubMed ID: 16921376
[TBL] [Abstract][Full Text] [Related]
9. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
Pinto AE; Pereira T; Silva GL; André S
Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H
Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219
[TBL] [Abstract][Full Text] [Related]
11. CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.
O'Brien SL; Fagan A; Fox EJ; Millikan RC; Culhane AC; Brennan DJ; McCann AH; Hegarty S; Moyna S; Duffy MJ; Higgins DG; Jirström K; Landberg G; Gallagher WM
Int J Cancer; 2007 Apr; 120(7):1434-43. PubMed ID: 17205517
[TBL] [Abstract][Full Text] [Related]
12. [Simplified, low-cost gene expression profiling for the prediction of outcome in breast cancer based on routine histologic specimens].
Szász AM; Ács B; Ágoston E; Sztupinszki Z; Tőkés AM; Szittya L; Székely B; Szendrői M; Li Q; Harsányi L; Tímár J; Szállási Z; Swanton C; Győrffy B; Kulka J
Orv Hetil; 2013 Apr; 154(16):627-32. PubMed ID: 23587542
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
14. DNA copy number aberrations associated with aneuploidy and chromosomal instability in breast cancers.
Kawauchi S; Furuya T; Ikemoto K; Nakao M; Yamamoto S; Oka M; Sasaki K
Oncol Rep; 2010 Oct; 24(4):875-83. PubMed ID: 20811667
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi Population.
Durrani S; Al-Mushawa F; Heena H; Wani T; Al-Qahtani A
Ann Diagn Pathol; 2021 Apr; 51():151674. PubMed ID: 33360027
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy.
Bièche I; Vacher S; Lallemand F; Tozlu-Kara S; Bennani H; Beuzelin M; Driouch K; Rouleau E; Lerebours F; Ripoche H; Cizeron-Clairac G; Spyratos F; Lidereau R
Mol Cancer; 2011 Feb; 10():23. PubMed ID: 21352579
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer.
Mo H; Wang X; Ma F; Qian Z; Sun X; Yi Z; Guan X; Li L; Liu B; Xu B
Breast; 2020 Oct; 53():111-118. PubMed ID: 32738630
[TBL] [Abstract][Full Text] [Related]
19. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
Mandard AM; Denoux Y; Herlin P; Duigou F; van De Vijver MJ; Clahsen PC; van Den Broek L; Sahmoud TM; Henry-Amar M; van De Velde CJ
Cancer; 2000 Oct; 89(8):1748-57. PubMed ID: 11042570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]